User contributions
Jump to navigation
Jump to search
- 00:18, 26 November 2020 diff hist +61 m Drug index →N
- 00:17, 26 November 2020 diff hist -2 m Naxitamab (Danyelza) →Diseases for which it is used
- 00:16, 26 November 2020 diff hist +3,016 N Naxitamab (Danyelza) FDA approval
- 23:50, 25 November 2020 diff hist 0 File:Apalutamide.pdf PeterYang uploaded a new version of File:Apalutamide.pdf
- 23:48, 25 November 2020 diff hist +5 m File:Naxitamab-gqgk.pdf current
- 23:48, 25 November 2020 diff hist +37 N File:Naxitamab.pdf PeterYang moved page File:Naxitamab.pdf to File:Naxitamab-gqgk.pdf current Tag: New redirect
- 23:48, 25 November 2020 diff hist 0 m File:Naxitamab-gqgk.pdf PeterYang moved page File:Naxitamab.pdf to File:Naxitamab-gqgk.pdf
- 23:47, 25 November 2020 diff hist +149 N File:Naxitamab-gqgk.pdf Naxitamab (Danyelza) package insert (locally hosted backup). Original source: https://labeling.ymabs.com/danyelza, accessed 11/25/2020.
- 20:45, 19 November 2020 diff hist +25 m Small cell lung cancer →Lurbinectedin monotherapy {{#subobject:35730b|Regimen=1}}: added NCT
- 20:42, 19 November 2020 diff hist +1,649 Small cell lung cancer added Lurbinectedin
- 20:28, 19 November 2020 diff hist 0 File:Trabectedin.pdf PeterYang uploaded a new version of File:Trabectedin.pdf current
- 20:28, 19 November 2020 diff hist +187 Trabectedin (Yondelis) updated links
- 20:26, 19 November 2020 diff hist -2 m Lurbinectedin (Zepzelca)
- 20:21, 19 November 2020 diff hist +2,843 N Lurbinectedin (Zepzelca) FDA approval
- 20:07, 19 November 2020 diff hist +87 m Drug index →L: added Lurbinectedin (Zepzelca) Tag: visualeditor
- 20:06, 19 November 2020 diff hist +167 N File:Lurbinectedin.pdf Lurbinectedin (Zepzelca) package insert (locally hosted backup). Original source: https://pp.jazzpharma.com/pi/zepzelca.en.USPI.pdf, accessed 11/19/2020. current
- 20:04, 19 November 2020 diff hist 0 File:Enzalutamide.pdf PeterYang uploaded a new version of File:Enzalutamide.pdf
- 14:22, 4 November 2020 diff hist +364 Performance status added ECOG-ACRIN link Tag: visualeditor
- 13:35, 4 November 2020 diff hist +433 Performance status →Comparing Karnofsky performance scale & ECOG performance status: updated KPS and ECOG comparison Tag: visualeditor
- 21:04, 26 October 2020 diff hist -178 m Editing test page Undo revision 46515 by PeterYang (talk) Tag: Undo
- 21:02, 26 October 2020 diff hist +178 m Editing test page test edits Tag: visualeditor
- 07:20, 24 October 2020 diff hist +887 Testicular cancer statistics and patient information links Tag: visualeditor
- 06:37, 19 October 2020 diff hist -9 m Editing test page 2 test edit Tag: visualeditor
- 16:39, 15 October 2020 diff hist +465 Pembrolizumab (Keytruda) →Classical Hodgkin lymphoma (cHL): FDA approval Tag: visualeditor
- 16:24, 15 October 2020 diff hist 0 File:Nivolumab.pdf PeterYang uploaded a new version of File:Nivolumab.pdf
- 16:22, 15 October 2020 diff hist 0 File:Ipilimumab.pdf PeterYang uploaded a new version of File:Ipilimumab.pdf
- 16:06, 15 October 2020 diff hist 0 File:Pembrolizumab.pdf PeterYang uploaded a new version of File:Pembrolizumab.pdf
- 16:04, 15 October 2020 diff hist 0 File:Pegfilgrastim.pdf PeterYang uploaded a new version of File:Pegfilgrastim.pdf current
- 20:34, 3 October 2020 diff hist +10 m Editing test page 2 Tag: visualeditor
- 20:32, 3 October 2020 diff hist +1,117 Enfortumab vedotin (Padcev) added package insert, links
- 20:32, 3 October 2020 diff hist +161 N File:Enfortumabvedotin.pdf Enfortumab vedotin (Padcev) package insert (locally hosted backup). Original source: https://astellas.us/docs/PADCEV_label.pdf, accessed 10/3/2020. current
- 11:19, 1 September 2020 diff hist +2 m Editing test page 2 Tag: visualeditor
- 11:18, 1 September 2020 diff hist -2 m Editing test page 2
- 15:24, 20 August 2020 diff hist +248 Publications and presentations mentioning HemOnc.org Tag: visualeditor
- 19:12, 16 August 2020 diff hist +191 m Pembrolizumab (Keytruda) →Bladder cancer
- 07:46, 17 July 2020 diff hist +9 m Editing test page 2 Tag: visualeditor
- 07:45, 17 July 2020 diff hist -15 m Editing test page 2
- 12:41, 4 June 2020 diff hist +2,415 N Relugolix (Orgovyx) Created page with "''Approved for use in Japan. Under investigation in United States.'' ==General information== Class/mechanism: Gonadotropin-releasing hormone (GnRH) receptor antagonist. Reve..."
- 12:18, 4 June 2020 diff hist +26 Drug index →R: added Relugolix
- 18:18, 3 June 2020 diff hist +508 N User:Akulkarni Created page with "thumb|Amit A. Kulkarni M.B.B.S. Amit A. Kulkarni M.B.B.S. is a hematology/oncology fellow at the University of Minnesota in Minneapolis, Minnesota...."
- 18:18, 3 June 2020 diff hist +54 N File:Amit Kulkarni.jpg Amit A. Kulkarni M.B.B.S. headshot photo current
- 20:27, 23 May 2020 diff hist +129 m Pembrolizumab (Keytruda) →Dosing
- 20:25, 23 May 2020 diff hist 0 File:Pembrolizumab.pdf PeterYang uploaded a new version of File:Pembrolizumab.pdf
- 15:13, 20 May 2020 diff hist +1,762 Prostate cancer →Olaparib monotherapy {{#subobject:defe72|Regimen=1}}
- 14:46, 20 May 2020 diff hist +479 Olaparib (Lynparza) FDA approval
- 14:43, 20 May 2020 diff hist 0 File:Olaparib.pdf PeterYang uploaded a new version of File:Olaparib.pdf
- 11:58, 7 May 2020 diff hist +35,915 Non-small cell lung cancer Undo revision 44917 by PeterYang (talk) -- added MET-mutated Tag: Undo
- 20:43, 6 May 2020 diff hist -1 m Non-small cell lung cancer, MET-mutated regimen/variant
- 20:00, 6 May 2020 diff hist +831 Daratumumab and hyaluronidase (Darzalex Faspro) added package insert, links
- 19:59, 6 May 2020 diff hist +252 N File:Daratumumab hyaluronidase-fihj.pdf Daratumumab and hyaluronidase-fihj (Darzalex Faspro) package insert (locally hosted backup). Original source: http://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/DARZALEX+Faspro-pi.pdf, accessed 5/6/2020. current